Twenty-Year Follow-Up of a Controlled Trial Comparing a Combination of Methotrexate Plus Cyclosporine with Cyclosporine Alone for Prophylaxis of Graft-versus-Host Disease in Patients Administered HLA-Identical Marrow Grafts for Leukemia-Reference-Cited by-同舟云学术

Twenty-Year Follow-Up of a Controlled Trial Comparing a Combination of Methotrexate Plus Cyclosporine with Cyclosporine Alone for Prophylaxis of Graft-versus-Host Disease in Patients Administered HLA-Identical Marrow Grafts for Leukemia

Published:2005-10 Issue:10 Volume:11 Page:814-815
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Sorror Mohamed L.,Leisenring Wendy,Deeg H. Joachim,Martin Paul J.,Storb Rainer

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference2 articles.

1. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia;Storb;N Engl J Med,1986

2. Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation;Pepe;Br J Haematol,1993

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic Stem-Cell Transplantation: Exploring the Latest Advances and Gaps in Disparities, Psychosocial and Symptom Management Interventions, and Chronic Graft-Versus-Host Disease Care;American Society of Clinical Oncology Educational Book;2024-06

2. Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT;Blood;2023-08-03

3. Designing and conducting a clinical trial in blood and marrow transplantation;Best Practice & Research Clinical Haematology;2023-06

4. Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice;Transplantation and Cellular Therapy;2022-08

5. Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation;Leukemia & Lymphoma;2022-02-10